Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

ExoRNA Bioscience

1 clinical trial

Clinical trial
An Open-Label, Dose Escalation Early Phase 1 Study of ER2001 Intravenous Injection in Adults With Early Manifest Huntington's Disease
Status: Recruiting, Estimated PCD: 2024-10-04